Showing results (301-310 of 345) with videos related to

Sort By:
Pageof 35
Journal of Critical Care|April 15, 2014
Heparin-induced thrombocytopenia in the critically ill: interpreting the 4Ts test in a randomized trialMark Crowther, Deborah Cook, Gordon Guyatt, et al.
NEJM Evidence|June 14, 2024
Proton-Pump Inhibitors to Prevent Gastrointestinal Bleeding - An Updated Meta-AnalysisYing Wang, Sameer Parpia, Long Ge, et al.
JAMA|March 25, 2020
Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017Jean-Louis Vincent, Yasser Sakr, Mervyn Singer, et al.
JAMA|June 12, 2024
Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III Randomized Clinical TrialJoel M Dulhunty, Stephen J Brett, Jan J De Waele, et al.
The New England Journal of Medicine|February 20, 2019
Adjunctive Intermittent Pneumatic Compression for Venous ThromboprophylaxisYaseen M Arabi, Fahad Al-Hameed, Karen E A Burns, et al.
BMC Medical Research Methodology|May 4, 2024
Protocol implementation during the COVID-19 pandemic: experiences from a randomized trial of stress ulcer prophylaxisBrittany Dennis, Adam Deane, François Lauzier, et al.
American Journal of Respiratory and Critical Care Medicine|May 2, 2025
Risk Factors for Patient-Important Upper Gastrointestinal BleedingAdam M Deane, François Lauzier, Neill K J Adhikari, et al.
The Lancet Regional Health. Western Pacific|July 13, 2026
Long-term survival in patients discharged alive from hospital following an intensive care unit admission with sepsis or septic shock in Australia and New Zealand: an observational cohort studyWin Wah, Alexis Paul Poole, Lewis Campbell, et al.
Trials|March 17, 2018
Statistical analysis plan for the Pneumatic CompREssion for PreVENting Venous Thromboembolism (PREVENT) trial: a study protocol for a randomized controlled trialYaseen Arabi, Fahad Al-Hameed, Karen E A Burns, et al.
American Journal of Respiratory and Critical Care Medicine|May 24, 2022
The Effect of a Liberal Approach to Glucose Control in Critically Ill Patients with Type 2 Diabetes: A Multicenter, Parallel-Group, Open-Label Randomized Clinical TrialAlexis P Poole, Mark E Finnis, James Anstey, et al.
Pageof 35